Innovatus Life Sciences Acquisition Corp. (ILAC)
Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
We intend to initially focus our search on identifying a prospective target business in the life sciences sector. Our sponsor is an affiliate of Innovatus Capital Partners, LLC, a boutique private equity firm with 27 professionals focused on creating value in special situations, growth equity, emerging asset classes, private credit and asset-based investments.
Since 2017, Innovatus Capital has evaluated numerous life sciences companies, investing in 15 companies and deployed over $370 million in capital to, among others, Personal Genome Diagnostics, Biodesix, Inc., Biotheranostics and Bionano Genomics, Inc.
|Industry||Blank Checks / SPAC|
777 Third Avenue, 25th Floor
New York, NY 10017
|Reporting Currency||US Dollars|
|David Schiff||Chief Executive Officer and Chairman of the Board of Directors|
|Andrew Hobson||Chief Financial Officer and Director|
|Claes Ekstrom||Chief Business Officer|